This renewal proposal for the Adult and Pediatric Rheumatology Training Program focuses on providing exceptional basic, translational and clinical research training to MD/MD PhD trainees interested in research careers studying autoimmunity and rheumatic diseases. A Selection Committee selects 5 of the most qualified candidates from the high quality pool of rheumatology and immunology fellows, as well as MD/MD PhD or PhD fellows from other departments who have strong commitments to these research areas. Physician fellows are eligible at the end of their clinical training and must commit to 2 years of training with >80% protected research time. Fellows can select training in either Basic and Translational Research (Track 1) or Clinical Investigation (Track 2).Training in each track will be comprised of a hypothesis-driven research project, required and recommended course work specific to the research track, and skill development (eg., grant and manuscript preparation) required for a successful independent research career. Trainees in Clinical Investigation (Track 2) are eligible for obtaining a Master of Science (MS) in epidemiology or health policy. These fellows should commit to 3 years of training to insure adequate time to complete. Other trainees in Track 2 have selected course work from the MS curriculum. In addition to course work, all trainees in both Tracks, required to attend weekly lectures in rheumatic diseases, journal clubs, immunology and rheumatology yearly retreats, semiannual T32 fellow specific retreats, and Responsible Conduct of Research courses. Multiple other offerings are specific to each Track such as Advanced Immunology Seminars or the Intensive Course in Clinical Research, and trainees are encouraged to cross-over when interested. These various courses, conferences and venues will provide opportunities for interactions between the rheumatology and immunology T32 trainees and the many other immunology fellows, faculty and students involved in the broad base of research at Stanford. Faculty mentors are selected carefully for their research expertise and mentoring competencies. Rigorous evaluation of the program identifies opportunities for improvement and progress toward goals. We will leverage Stanford's rich research and training culture to provide the environment to train the next generation of academic independent investigators in rheumatology and Immunology.

Public Health Relevance

In order to meet future public health needs of the nation this educational training program provides exceptional research training to MD, MD Ph.D. or PhD trainees in adult and pediatric rheumatology and immunology to study autoimmunity and rheumatic diseases. It will train the next generation of translational and clinical research investigators to take advantage of new breakthroughs in understanding disease pathophysiology and the resultant potential for development of innovative therapy in both adult and pediatric rheumatic diseases. The long-term goal is to enable the trainees to become independent investigators and academic physician-scientist leaders of the future.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Institutional National Research Service Award (T32)
Project #
2T32AR050942-11
Application #
9077405
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Program Officer
Wang, Yan Z
Project Start
2004-04-01
Project End
2021-04-30
Budget Start
2016-05-01
Budget End
2017-04-30
Support Year
11
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Stanford University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304
Zhang, Yujuan; Gupta, Saloni; Ilstad-Minnihan, Alexandra et al. (2018) Interleukin-1 in monocyte activation phenotypes in systemic juvenile idiopathic arthritis: Observations from a clinical trial of rilonacept, an interleukin-1 inhibitor. Clin Immunol 194:9-18
Favier, Leslie A; Taylor, Janalee; Loiselle Rich, Kristin et al. (2018) Barriers to Adherence in Juvenile Idiopathic Arthritis: A Multicenter Collaborative Experience and Preliminary Results. J Rheumatol 45:690-696
Kolstad, Kathleen D; Li, Shufeng; Steen, Virginia et al. (2018) Long-Term Outcomes in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS). Chest 154:862-871
Kolstad, Kathleen D; Fiorentino, David; Li, Shufeng et al. (2018) Pregnancy outcomes in adult patients with dermatomyositis and polymyositis. Semin Arthritis Rheum 47:865-869
Cheung, Peggie; Vallania, Francesco; Warsinske, Hayley C et al. (2018) Single-Cell Chromatin Modification Profiling Reveals Increased Epigenetic Variations with Aging. Cell 173:1385-1397.e14
Chinthrajah, R Sharon; Purington, Natasha; Andorf, Sandra et al. (2018) Development of a tool predicting severity of allergic reaction during peanut challenge. Ann Allergy Asthma Immunol 121:69-76.e2
Blum, Lisa K; Cao, Richard R L; Sweatt, Andrew J et al. (2018) Circulating plasmablasts are elevated and produce pathogenic anti-endothelial cell autoantibodies in idiopathic pulmonary arterial hypertension. Eur J Immunol 48:874-884
Zhao, Yongdong; Wu, Eveline Y; Oliver, Melissa S et al. (2018) Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and/or With Active Spinal Lesions. Arthritis Care Res (Hoboken) 70:1228-1237
Geraldino-Pardilla, Laura; Russo, Cesare; Sokolove, Jeremy et al. (2017) Association of anti-citrullinated protein or peptide antibodies with left ventricular structure and function in rheumatoid arthritis. Rheumatology (Oxford) 56:534-540
Tedeschi, Sara K; Cui, Jing; Arkema, Elizabeth V et al. (2017) Elevated BMI and antibodies to citrullinated proteins interact to increase rheumatoid arthritis risk and shorten time to diagnosis: A nested case-control study of women in the Nurses' Health Studies. Semin Arthritis Rheum 46:692-698

Showing the most recent 10 out of 59 publications